Clinical course of thrombocytopenia in patients treated with imatinib mesylate for accelerated phase chronic myelogenous leukemia.

van Deventer, Hendrik W

Clinical course of thrombocytopenia in patients treated with imatinib mesylate for accelerated phase chronic myelogenous leukemia. [electronic resource] - American journal of hematology Nov 2002 - 184-90 p. digital

Publication Type: Clinical Trial; Comparative Study; Journal Article

0361-8609

10.1002/ajh.10215 doi


Antineoplastic Agents--administration & dosage
Benzamides
Cell Count
Cytogenetic Analysis
Disease Progression
Dose-Response Relationship, Drug
Humans
Imatinib Mesylate
Leukemia, Myeloid, Accelerated Phase--drug therapy
Megakaryocytes--pathology
Piperazines--administration & dosage
Pyrimidines--administration & dosage
Thrombocytopenia--chemically induced
Time Factors